D&D Pharmatech has raised $190M in total funding. Latest round: IPO. Backed by Smilegate Investment, InterVest, Quantum Frontier.
D&D Pharmatech funding overview
D&D Pharmatech has raised $190M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in May 2024. The round record for D&D Pharmatech runs through 2024; nothing later has been disclosed. Investors on record include Smilegate Investment, InterVest, Quantum Frontier, DS Asset Management, KTB Network. 5 distinct backers are named across the disclosed rounds.
D&D Pharmatech has raised $190M in total disclosed funding across the rounds on record.
Who has invested in D&D Pharmatech?
Smilegate Investment, InterVest, Quantum Frontier, DS Asset Management, KTB Network are named among the investors backing D&D Pharmatech.
What was the latest D&D Pharmatech funding round?
The most recent disclosed round is an IPO, announced in May 2024.
Where is D&D Pharmatech based?
No headquarters location is disclosed for D&D Pharmatech.
When did D&D Pharmatech last raise?
The last disclosed D&D Pharmatech round closed in May 2024 at IPO.
Totals shown for D&D Pharmatech aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
